Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Buccisano

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Haematologica|September 4, 2025
Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panelSa A Wang, Leonor Arenillas, Francesco Buccisano, et al.
Haematologica|April 16, 2026
Response to Comment on: "Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel"Sa A Wang, Leonor Arenillas, Francesco Buccisano, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2013
Treatment of acute myeloid leukemia with 20-30% bone marrow blastsLuca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance StudyAntonella Poloni, Klas Raaschou-Jensen, Francisca Hernandez Mohedo, et al.
Cancer|November 14, 2007
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, et al.
Leukemia & Lymphoma|April 12, 2003
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemiaAdriano Venditti, Luca Maurillo, Francesco Buccisano, et al.
Haematologica|December 14, 2004
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Ejhaem|December 18, 2024
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practiceMonica Messina, Alfonso Piciocchi, Leonardo M Siena, et al.
Frontiers in Oncology|October 3, 2022
Case report: A <i>Saprochaete clavata</i> (<i>Magnusiomyces clavatus</i>) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcomaGianmario Pasqualone, Elisa Buzzatti, Raffaele Palmieri, et al.
Blood|October 26, 2007
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemiaValter Gattei, Pietro Bulian, Maria Ilaria Del Principe, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Haematologica|September 4, 2025
Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panelSa A Wang, Leonor Arenillas, Francesco Buccisano, et al.
Haematologica|April 16, 2026
Response to Comment on: "Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel"Sa A Wang, Leonor Arenillas, Francesco Buccisano, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 25, 2013
Treatment of acute myeloid leukemia with 20-30% bone marrow blastsLuca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance StudyAntonella Poloni, Klas Raaschou-Jensen, Francisca Hernandez Mohedo, et al.
Cancer|November 14, 2007
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, et al.
Leukemia & Lymphoma|April 12, 2003
Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemiaAdriano Venditti, Luca Maurillo, Francesco Buccisano, et al.
Haematologica|December 14, 2004
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Ejhaem|December 18, 2024
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real-world practiceMonica Messina, Alfonso Piciocchi, Leonardo M Siena, et al.
Frontiers in Oncology|October 3, 2022
Case report: A <i>Saprochaete clavata</i> (<i>Magnusiomyces clavatus</i>) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcomaGianmario Pasqualone, Elisa Buzzatti, Raffaele Palmieri, et al.
Blood|October 26, 2007
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemiaValter Gattei, Pietro Bulian, Maria Ilaria Del Principe, et al.
Pageof 15